Blood Screening Industry Development, Growth and Forecast Report 2030Posted by Aryan on October 17th, 2023 The blood screening market is witnessing growth, the expansion of the industry can be credited to the developments in blood screening tech, severe guidelines concerning polluted blood, rising healthcare expenditure, and high occurrence of chronic, respiratory, and infectious illnesses. The reagents and kits category, under the product type segment, held the largest market share in 2019. This was due to the requirement for these products during the first stage of the blood screening procedure and the easy availability of several reagents. Besides, the high preference for fast, reliable, and specific detection of transfusion transmissible diseases (TTD) also fueled the adoption of these products. In recent years, on the basis of type, the reagents and kits category had the largest industry share. This is mainly because of the need for such items in the first level of the blood screening process and the easy obtainability of numerous reagents. Also, the high fondness for specific, fast, and reliable discovery of transfusion transmissible diseases (TTD) also boosted the acceptance of such items. Download free sample copy of this report: https://www.psmarketresearch.com/market-analysis/blood-screening-market/report-sample The nucleic acid technology category, within the technology section of the blood screening market, will experience the fastest development in the coming years. This is mainly because this tech is very common among blood banks and testing labs, because of its advanced sensitivity in comparison to the others. The human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) category, on the basis of type segment, is projected to produce the highest revenue in the blood screening market during the projection period. Individuals are compulsorily screened for HIV/AIDS before giving blood to anyone. The growing incidence of this illness will, thus, boost the development of this category in the blood screening industry. As per the WHO, there have been 37.9 cases of HIV/AIDS globally in recent years. Also, the blood banks category, within the end-user segment of the industry for blood screening solutions, is responsible for the key share, because of the rising count of blood donation activities and organ transplant operations. Furthermore, the rising knowledge about the risks of polluted blood fuelled this category’s development. The highest revenue in the market in recent years is attributed to North America, which has a high incidence of infectious and respiratory diseases. For sample, North America recorded the highest COVID-19 cases (around 560,000) and deaths (nearly 22,100) till April 13, 2020. Furthermore, the launch of new items by key players, mainly for COVID testing, like the CoronaCheck antibody test kit by BioResponse, is also playing an important role in the development of the industry in the continent. Moreover, the increasing government aid regarding the utilization of progressive screening items is also a major development propeller of the blood screening industry in this region. About P&S Intelligence P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges. Contact: Like it? Share it! More by this author |